Glucagon Supports Postabsorptive Plasma Glucose Concentrations in Humans With Biologically Optimal Insulin Levels

OBJECTIVE: Based on the premise that postabsorptive patients with type 1 diabetes receiving intravenous insulin in a dose that maintains stable euglycemia are receiving biologically optimal insulin replacement, we tested the hypothesis that glucagon supports postabsorptive plasma glucose concentrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooperberg, Benjamin A., Cryer, Philip E.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963554/
https://www.ncbi.nlm.nih.gov/pubmed/20699417
http://dx.doi.org/10.2337/db10-0750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963554/
https://www.ncbi.nlm.nih.gov/pubmed/20699417
http://dx.doi.org/10.2337/db10-0750

Ejemplares similares